Merck KGaA (OTCMKTS:MKGAF) Hits New 52-Week Low – Time to Sell?

Merck KGaA (OTCMKTS:MKGAF) reached a new 52-week low on Tuesday . The company traded as low as $144.39 and last traded at $145.07, with a volume of 4667 shares. The stock had previously closed at $147.65.

Analysts Set New Price Targets

Separately, The Goldman Sachs Group upgraded shares of Merck KGaA to a “strong-buy” rating in a report on Thursday, September 19th.

Merck KGaA Price Performance

The stock has a market cap of $18.75 billion, a PE ratio of 21.68 and a beta of 0.96. The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.84 and a current ratio of 1.31. The stock’s 50-day moving average is $170.08 and its two-hundred day moving average is $175.87.

About Merck KGaA

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.